Liquid biopsies represent a less invasive method to detect and monitor cancer. They analyze free-floating cancer DNA or other biomarkers in the blood, offering a snapshot of the genetic landscape of the tumor. This technique can help in early detection, monitoring treatment response, and detecting recurrences. Liquid biopsies hold the potential to complement traditional tissue biopsies, providing a more comprehensive understanding of the disease.
